Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Research Articles

Vol. 12 No. 1 (2025)

Identification and in-silico analysis of phytochemicals from Phyla nodiflora (L.): Potential bioactive compounds for therapeutic applications

DOI
https://doi.org/10.14719/pst.5908
Submitted
17 October 2024
Published
27-12-2024 — Updated on 01-01-2025
Versions

Abstract

The increasing demand for safer and more sustainable alternatives to chemical based medicines has driven significant interest in plant-derived bioactive compounds, which possess a wide range of therapeutic properties. Among these, Phyla nodiflora (L.), a medicinal plant traditionally used in various remedies, has garnered attention for its potential in treating numerous ailments. However, a comprehensive understanding of the bioactive compounds in P. nodiflora and their mechanisms of action remain limited. In this context, the present study aims to explore the therapeutic potential of phytochemicals derived from the hexane and methanolic leaf extract of P.
nodiflora. Using GC-MS (gas chromatography and mass spectrometry) analysis, 50 distinct chemical compounds were identified, from which the 10 most predominant bioactive compounds were selected for further investigation
based on their known pharmacological properties. These compounds were subjected to molecular docking studies against key protein targets, including protein tyrosine phosphatase 1B, androgen receptor, cyclin A, and Na-K-Cl
Cotransporter 1 (NKCC1). The findings revealed that n-hexadecanoic acid, stigmasterol, and beta-sitosterol exhibit significant potential as drug candidates, demonstrating promising therapeutic applications for conditions such as diabetes, alopecia, cancer, and anti-diuresis. These findings provide valuable insights into the medicinal value of P. nodiflora, paving the way for further research, including in vitro and in vivo studies, to validate the efficacy of
these compounds. Additionally, the study underscores the importance of plant based drug discovery in the development of novel treatments for noncommunicable diseases, thereby contributing to the growing body of research in ethnopharmacology and natural product chemistry.

References

  1. 1. Arumanayagam S, Arunmani M. Hepatoprotective and antibacterial activity of Lippia nodiflora Linn. against lipopolysaccharides on HepG2 cells. Pharmacogn Mag. 2015;11(41):24-31. https://doi.org/10.4103/0973-1296.149689
  2. 2. Khdera HA, Saad SY. Chemical composition of organic extracts of Phyla nodiflora L. in Syria by GC-MS. Heliyon. 2024;10(14):e34686. https://doi.org/10.1016/j.heliyon.2024.e34686
  3. 3. Alafnan A, Nadeem MF, Ahmad SF, Sarfraz M, Aalamri A, Khalifa NE, et al. A comprehensive assessment of phytochemicals from Phyla nodiflora (L.) Greene as a potential enzyme inhibitor and their biological potential: An in-silico, in-vivo and in-vitro approach. Arab J Chem. 2023;16(11):105233. https://doi.org/10.1016/j.arabjc.2023.105233
  4. 4. Sadgrove NJ. The new paradigm for androgenetic alopecia and plant-based folk remedies: 5 alpha-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance. J Ethnopharmacol. 2018;227:206-36. https://doi.org/10.1016/j.jep.2018.09.009
  5. 5. Teimouri M, Hosseini H, ArabSadeghabadi Z, Babaei-Khorzoughi R, Gorgani-Firuzjaee S, Meshkani R. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications. J Physiol Biochem. 2022;1-16. https://doi.org/10.1007/s13105-021-00860-7
  6. 6. Zhuo F, Xu W, Wang L, Wu Y, Xu Z, Zhao J. Androgen receptor gene polymorphisms and risk for androgenetic alopecia: A meta-analysis. Clin Exp Dermatol. 2012;37(2):104-11. https://doi.org/10.1111/j.1365-2230.2011.04186.x
  7. 7. Ding L, Cao J, Lin W, Chen H, Xiong X, Ao H, et al. The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. Int J Mol Sci. 2020;21(6):1960. https://doi.org/10.3390/ijms21061960
  8. 8. Koumangoye R, Bastarache L, Delpire E. NKCC1: Newly found as a human disease-causing ion transporter. Function. 2021;2(1):zqaa028. https://doi.org/10.1093/function/zqaa028
  9. 9. Furlan V, Konc J, Bren U. Inverse molecular docking as a novel approach to study anticarcinogenic and anti-neuroinflammatory effects of curcumin. Molecules. 2018;23(12):3351. https://doi.org/10.3390/molecules23123351
  10. 10. Iman K, Mirza MU, Mazhar N, Vanmeert M, Irshad I, Kamal MA. In silico structure-based identification of novel acetylcholinesterase inhibitors against Alzheimer's disease. CNS Neurol Disord Drug Targets. 2018;17(1):54-68. https://doi.org/10.2174/1871527317666180115162422
  11. 11. Balamurugan R, Duraipandiyan V, Ignacimuthu S. Antidiabetic activity of gamma-sitosterol isolated from Lippia nodiflora L. in streptozotocin induced diabetic rats. Eur J Pharmacol. 2011;667(1-3):410-18. https://doi.org/10.1016/j.ejphar.2011.05.025
  12. 12. Sudha A, Srinivasan P. Physicochemical and phytochemical profiles of aerial parts of Lippia nodiflora L. Int J Pharm Sci Res. 2013;4(11):4263. http://dx.doi.org/10.13040/IJPSR.0975-8232.4(11).4263-71
  13. 13. Purushothaman R, Vishnuram MG, Ramanathan DT. Isolation and identification of N-hexadecanoic acid from Excoecaria agallocha L. and its antibacterial and antioxidant activity. JETIR. 2024;11(1):332-42. https://dx.doi.org/10.2139/ssrn.4886224
  14. 14. Balakrishna K, Gopal RH, Ramkumar V, Rao RB, Vasanth S, Narayanappa D. Antibacterial acivity of the essential oil of Lippie nodiflora. Anc Sci Life. 1996;16(1):79-81.
  15. 15. Teoh PL, Liau M, Cheong BE. Phyla nodiflora L. extracts induce apoptosis and cell cycle arrest in human breast cancer cell line, MCF-7. Nutr Cancer. 2019;71(4):668-75. https://doi.org/10.1080/01635581.2018.1559942

Downloads

Download data is not yet available.